DeutschNewstral
Article
bizjournals.com on 2020-11-24 11:27
FDA approves Alnylam's first-ever drug for rare kidney disease
Related news
- FDA approves CSL Behring rare disease treatmentbizjournals.com
- PFDA approves Amgen’s Parsabiv drug to treat chronic kidney diseasepacbiztimes.com
- FFDA approves first drug to treat rare kidney-related conditionfoxnews.com
- FDA approves ultra-rare disease drug from Waltham's Sobibizjournals.com
FDA Approves Merck’s New Drug For A Rare Lung DiseaseForbes- SFDA approves drug for cats with chronic kidney disease, giving pet owners hopesilive.com
- FDA approves CSL Behring therapy for rare disease that can be administered at homebizjournals.com
- MFDA approves Viela's rare disease treatment, analysts predict $500 million in salesmarketwatch.com
- MCelgene's rare disease drug gets FDA approvalmarketwatch.com
Downers Grove girl dies of rare disease one year after FDA approves treatment her parents fought forChicago Tribune- MFDA approves Reata's rare disease drug amid questions about changes to the regulatory environment for neuroscience treatments3 min readmarketwatch.com
FDA Approves Drug to Treat Parkinson’s Diseaseexploreclarion.com
FDA approves $2.1M drug for baby diseasenwaonline.com- PFDA to review Amgen’s new kidney disease dugpacbiztimes.com
US FDA approves Merck's drug for kidney cancerThe Jerusalem Post (JPost.com)
FDA approves Keytruda as adjuvant treatment for kidney cancerFox News
FDA approves $2M medicine, most expensive everabqjournal.com- FDA approves first-ever Ebola vaccineFox News
FDA Approves First-Ever Prescription Video Gameslate.com